| Previous Close | 58.22 |
| Open | 58.05 |
| Bid | 57.84 x 100 |
| Ask | 57.91 x 100 |
| Day's Range | 57.63 - 58.59 |
| 52 Week Range | 30.69 - 59.99 |
| Volume | 50,391 |
| Avg. Volume | 369,975 |
| Market Cap | 3.37B |
| Beta | 1.97 |
| PE Ratio (TTM) | -111.48 |
| EPS (TTM) | -0.52 |
| Earnings Date | Nov 1, 2017 - Nov 6, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 58.15 |
- Business Wire•7 days ago
Insulet Corporation Presents Real-World Clinical Data on the Use of Its Omnipod® Insulin Management System in Approximately 39,000 Patients Using a Cloud-Based Data Management System
Insulet Corporation , the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System , today presented real-world clinical data at the Congress of the European Association for the Study of Diabetes in Lisbon, Portugal.
Markit•8 days agoSee what the IHS Markit Score report has to say about Insulet Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Markit•9 days agoSee what the IHS Markit Score report has to say about Insulet Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
